Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer

Journal of Surgical Oncology

Volumn 75, Issue 4, 2000, Pages 252-257

  Shpitz, Baruch ^a,c   Bomstein, Yonit ^a,c   Sternberg, Ahud ^b   Klein, Ehud ^a,c   Liverant, Sigal ^a,c   Groisman, Gabriel ^b   Bernheim, Joelle ^a,c  

^a MEIR MEDICAL CENTER   (Israel)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Biomarkers; c erbB 2; Male breast cancer; p53; Prognosis

Indexed keywords

BIOTIN; CANCER ANTIBODY; CD34 ANTIGEN; ESTROGEN RECEPTOR; PROTEIN P53; STREPTAVIDIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION FUNCTION; DISEASE MARKER; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034523340     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200012)75:4<252::AID-JSO5>3.0.CO;2-2     Document Type: Article

References (33)

1. Biologic indices in the assessment of breast cancer
2. Molecular pathology of breast cancer and its implication to clinical management
3. Molecular genetics of human breast cancer
4. Molecular mechanisms involved in tumorigenesis and their surgical implications
5. Genetic alterations in breast cancer
6. Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumor suppressor gene p53
7. Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic factors
8. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more then a new prognostic tool
9. Carcinoma of the breast in males. A Multi-Institutional survey
10. The prognosis of breast cancer in males
11. Estrogen receptor analyses
12. Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer
13. C-erbB-2 amplification in mammary carcinoma
14. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
15. c-erbB-2 oncogene as a prognostic marker in breast cancer
16. Pathological findings from the national NSABBP project: Prognostic significance of c-erbB-2 protein overexpression in primary breast cancer
17. Prognostic importance of c-erbB-2 expression in breast cancer
18. Lack of c-erbB-2 oncoprotein expression in male breast carcinoma
19. Male breast cancer: An evaluation of prognostic factors contributing to a poorer prognosis
20. Male breast cancer: Pathological and immunohistochemical features
21. Male breast cancer: Clinicopathological features, immunocytochemical features and prognosis
22. Clinical implications of the p53 gene
23. p53 gene expression in node-positive breast cancer: Relationship to DNA ploidy and prognosis
24. Tumor microvessel density, p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast cancer
25. P53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer
26. Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up
27. P53 gene mutations and steroid receptor status in breast cancer. Clinicopathological correlation and prognostic assessment
28. Somatic p53 mutations in human breast carcinomas in an Icelandic population: A prognostic factor
29. Molecular markers in male breast cancer
30. Mechanisms of apoptosis: Integration of genetic, biochemical and cellular indicators
31. Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas
32. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma
33. Tumor angiogenesis: A new significant and independent prognostic factor in early-stage breast carcinoma